Sector | Healthcare | Compare with Sector peers |
Industry | Pharmaceuticals & Drugs | Compare with Industry peers |
Website | http://www.pghealthindia.com | |
Market Cap | 7,783.87 Cr. | |
Enterprise Value(EV) | 7,430.18 Cr. | 2023-12 |
Financial Indicators | ||
---|---|---|
Earnings per share (EPS) | 136.54 | Trailing Twelve Months Ending 2023-12 |
Price-Earning Ratio (PE) | 34.34 | Trailing Twelve Months Ending 2023-12 |
Industry PE | 41.15 | Trailing Twelve Months Ending 2023-12 |
Book Value / Share | 485.49 | Trailing Twelve Months Ending 2023-12 |
Price to Book Value | 9.73 | Calculated using Price: 4,722.90 |
Dividend Yield | 2.03 | Period Ending 2023-06 |
No. of Shares Subscribed | 1.66 Cr. | 16,599,382 Shares |
FaceValue | 10 | |
About Procter & Gamble Health Ltd. | ||
Till 2018, the Company was operating in all businesses included in the pharmaceuticals and chemicals businesses in the country. The company is one of India's largest VMS Companies manufacturing and marketing over-the-counter products, vitamins, minerals, and supplements products for a healthy lifestyle and improved quality of life. Its trusted products are household names in India protecting and supporting millions of people at every stage of life. |
1 Day |
|
-0.71% |
1 Week |
|
-2.46% |
1 Month |
|
-7.39% |
3 Month |
|
-4.82% |
6 Month |
|
-6.93% |
1 Year |
|
-3.47% |
2 Year |
|
+11.33% |
5 Year |
|
+35.67% |
10 Year |
|
+646.83% |
9 years | 2014-12 | 2015-12 | 2016-12 | 2017-12 | 2018-12 | 2020-06 | 2021-06 | 2022-06 | 2023-06 | |
Return on Equity (%) | 8.02 | 9.35 | 12.61 | 8.74 | 8.95 | 20.79 | 22.04 | 29.41 | 33.94 | |
Return on Capital Employed (%) | 12.36 | 14.54 | 18.35 | 14.16 | 13.9 | 29.01 | 29.08 | 38.45 | 46.07 | |
Return on Assets (%) | 4.37 | 3.92 | 5.48 | 4.24 | 4.96 | 10.82 | 8.65 | 9.83 | 11 |
Particulars | 10 years | 2014-12 Rs. Cr. | 2015-12 Rs. Cr. | 2016-12 Rs. Cr. | 2017-12 Rs. Cr. | 2018-12 Rs. Cr. | 2020-06 Rs. Cr. | 2021-06 Rs. Cr. | 2022-06 Rs. Cr. | 2023-06 Rs. Cr. | 2023-12* Rs. Cr. |
Shh. Funds | 554 | 592 | 664 | 733 | 1,540 | 906 | 704 | 616 | 751 | 806 | |
Non Curr. Liab. | 390 | 395 | 399 | 431 | 495 | 667 | 723 | 714 | 803 | 14 | |
Curr. Liab. | 260 | 539 | 301 | 352 | 548 | 539 | 551 | 608 | 679 | 231 | |
Minority Int. | |||||||||||
Equity & Liab. | 1,204 | 1,525 | 1,363 | 1,516 | 2,583 | 2,112 | 1,978 | 1,938 | 2,233 | 1,050 | |
Non Curr. Assets | 581 | 579 | 613 | 637 | 693 | 847 | 939 | 954 | 1,062 | 279 | |
Curr. Assets | 623 | 946 | 750 | 879 | 1,889 | 1,265 | 1,039 | 984 | 1,171 | 771 | |
Misc. Exp. not W/O | |||||||||||
Total Assets | 1,204 | 1,525 | 1,363 | 1,516 | 2,583 | 2,112 | 1,978 | 1,938 | 2,233 | 1,050 |
Particulars | 10 years | 2014-12 Rs. Cr. | 2015-12 Rs. Cr. | 2016-12 Rs. Cr. | 2017-12 Rs. Cr. | 2018-12 Rs. Cr. | 2020-06 Rs. Cr. | 2021-06 Rs. Cr. | 2022-06 Rs. Cr. | 2023-06 Rs. Cr. | 2023-12 Rs. Cr. TTM |
Net Sales | 867 | 940 | 993 | 698 | 849 | 1,356 | 1,009 | 1,114 | 1,230 | 1,237 | |
Other Income | 20 | 23 | 24 | 30 | 28 | 70 | 18 | 13 | 18 | 22 | |
Total Income | 888 | 963 | 1,017 | 729 | 877 | 1,426 | 1,027 | 1,128 | 1,248 | 1,259 | |
Total Expenditure | -809 | -856 | -877 | -628 | -705 | -1,042 | -763 | -847 | -905 | -922 | |
PBIDT | 79 | 107 | 140 | 101 | 173 | 384 | 264 | 281 | 343 | 337 | |
Interest | -1 | 0 | -1 | -1 | |||||||
Depreciation | -13 | -23 | -25 | -19 | -21 | -29 | -30 | -27 | -28 | -26 | |
Taxation | -23 | -30 | -36 | -38 | -56 | -101 | -56 | -61 | -85 | -84 | |
Exceptional Items | 17 | 7 | |||||||||
PAT | 43 | 54 | 79 | 61 | 102 | 254 | 177 | 193 | 229 | 227 | |
Adjusted EPS | 26 | 32 | 48 | 37 | 61 | 153 | 107 | 116 | 138 | 137 |
Particulars | 10 years | 2013-12 Rs. Cr. | 2014-12 Rs. Cr. | 2015-12 Rs. Cr. | 2016-12 Rs. Cr. | 2017-12 Rs. Cr. | 2018-12 Rs. Cr. | 2020-06 Rs. Cr. | 2021-06 Rs. Cr. | 2022-06 Rs. Cr. | 2023-06 Rs. Cr. |
Cash Fr. Operatn. | 0 | 5 | 83 | 107 | 54 | -130 | 235 | 247 | 170 | 236 | |
Cash Fr. Inv. | 7 | 11 | -68 | -75 | -48 | 1,270 | 165 | -32 | -26 | -22 | |
Cash Fr. Finan. | -5 | -17 | -12 | -15 | -22 | -30 | -883 | -387 | -289 | -98 | |
Net Change | 3 | -1 | 4 | 17 | -16 | 1,109 | -483 | -172 | -145 | 116 | |
Cash & Cash Eqvt | 7 | 5 | 9 | 26 | 10 | 1,119 | 636 | 464 | 319 | 435 |
Wed, 27 Mar 2024
Trading Window Procter & Gamble Health Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015 |
Wed, 27 Mar 2024
Loss/Duplicate-Share Certificate-XBRL Procter & Gamble Health Limited has informed the Exchange about Loss of share certificates |
Wed, 27 Mar 2024
Loss of Share Certificates Procter & Gamble Health Limited has informed the Exchange about Loss of Share Certificates |
Wed, 27 Mar 2024 |
High Delivery Percentage |
Higher Delivery Quantity |
Higher Delivery Quantity and Percentage |
Higher Trade Quantity |
Higher Trade and Delivery Quantity |